Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

UroGen Pharma Ltd.

URGN · Nasdaq · CIK 0001668243 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

14 Form 4 transaction lines observed in the same window
8 sales · 6 option, withholding, award, gift or other lines

Last qualifying purchase2021-11-18 · Schoenberg Mark · $2.1K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Schoenberg MarkChief Medical Officer
▼○▼▼▼▼○▼
Robinson James A. Jr.Director
○○
Smith Jason DrewGeneral Counsel
○▼
Degnan ChrisChief Financial Officer
○▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2021-11-18 · Schoenberg Mark.

Recent Form 4 activity

0Purchases
15Sales
17Other Form 4 lines
19SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING8 sale line(s) · context only
OTHER6 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
7,766,918
Previous report
6,247,498
Avg daily volume
783,547
Days to cover
9.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2021-11-18Schoenberg MarkPurchase (P)Ordinary Shares160USD 13.10USD 2,096SEC filing ↗
2021-05-17Smith Jason DrewPurchase (P)Common Stock2,500USD 15.71USD 39,275SEC filing ↗
2021-05-17Henderson MollyPurchase (P)Common Stock2,500USD 15.85USD 39,625SEC filing ↗
2020-12-14Barrett Elizabeth A.Purchase (P)Ordinary Shares10,000USD 18.50USD 185,000SEC filing ↗

Form 4 evidence

32 transaction lines in the latest 365-day window; 216 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08Degnan ChrisSale (S)Ordinary Shares2,202USD 36.69USD 80,791SEC filing ↗
2026-10-08Degnan ChrisOption exercise / conversion (M)Ordinary Shares4,483USD —USD —SEC filing ↗
2026-09-08Smith Jason DrewSale (S)Ordinary Shares1,519USD 42.54USD 64,618SEC filing ↗
Show recent Form 4 evidence (24 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-08Degnan ChrisSale (S)Ordinary Shares2,202USD 36.69USD 80,791SEC filing ↗
2026-10-08Degnan ChrisOption exercise / conversion (M)Ordinary Shares4,483USD —USD —SEC filing ↗
2026-09-08Smith Jason DrewSale (S)Ordinary Shares1,519USD 42.54USD 64,618SEC filing ↗
2026-09-08Schoenberg MarkSale (S)Ordinary Shares871USD 42.92USD 37,383SEC filing ↗
2026-09-07Smith Jason DrewOption exercise / conversion (M)Ordinary Shares3,334USD —USD —SEC filing ↗
2026-09-07Schoenberg MarkOption exercise / conversion (M)Ordinary Shares1,667USD —USD —SEC filing ↗
2026-08-26Robinson James A. Jr.Option exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2026-08-20Schoenberg MarkSale (S)ordinary shares60,677USD 47.05USD 2,854,853SEC filing ↗
2026-07-09Schoenberg MarkSale (S)Ordinary Shares10,000USD 40.00USD 400,000SEC filing ↗
2026-06-22Schoenberg MarkSale (S)Ordinary Shares10,000USD 35.01USD 350,100SEC filing ↗
2026-06-08Schoenberg MarkSale (S)Ordinary Shares5,222USD 27.30USD 142,561SEC filing ↗
2026-06-08Schoenberg MarkOption exercise / conversion (M)Ordinary Shares10,000USD —USD —SEC filing ↗
2026-05-26Robinson James A. Jr.Option exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2026-05-08Schoenberg MarkSale (S)Ordinary Shares10,000USD 30.00USD 300,000SEC filing ↗
2026-02-03Smith Jason DrewSale (S)Ordinary Shares7,479USD 19.69USD 147,262SEC filing ↗
2026-02-03Schoenberg MarkSale (S)Ordinary Shares7,373USD 19.69USD 145,174SEC filing ↗
2026-01-31Smith Jason DrewOption exercise / conversion (M)Ordinary Shares15,500USD —USD —SEC filing ↗
2026-01-31Schoenberg MarkOption exercise / conversion (M)Ordinary Shares13,333USD —USD —SEC filing ↗
2025-11-26Wildman Daniel GeorgeOption exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2025-11-26WEN LEANAOption exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2025-11-26Robinson James A. Jr.Option exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2025-11-26Holden StuartOption exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2025-11-26BUTITTA CYNTHIA MOption exercise / conversion (M)ordinary shares2,000USD —USD —SEC filing ↗
2025-11-19Schoenberg MarkSale (S)Ordinary Shares10,000USD 25.00USD 250,000SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerURGN
CIK0001668243
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history216 transaction lines from 2020-01-03 to 2026-10-08
4 P purchase lines · 90 S sale lines · 122 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.